生物標記研究服務市場按服務類型、適應症、最終用戶和地區分類

2025 年全球生物標記研究服務市場規模估計為 109.8 億美元，預計到 2032 年將達到 3,106.6 億美元，2025 年至 2032 年的複合年成長率為 61.2%。

圖。

隨著精準醫療和個人化醫療的日益普及，全球生物標記研究服務市場在過去幾年中獲得了顯著的發展。生物標記透過識別疾病風險和患者對治療的反應在藥物開發中發揮關鍵作用。生物標記可以幫助簡化臨床測試並降低與藥物開發相關的成本。隨著生物標記在疾病早期診斷和標靶治療開發中越來越受到關注，對生物標記研究外包服務的需求正在迅速成長。各種生物製藥公司與研究機構合作，以利用他們的專業知識並最大限度地提高臨床研究的效率。這推動了全球生物標記研究服務市場的成長。

市場動態

全球生物標記研究服務市場受到個人化醫療需求不斷成長、精準醫療影響力不斷擴大以及伴同性診斷市場成長的推動。然而，與生物標記發現和檢驗相關的高成本以及生物標記發現的技術挑戰可能會抑制市場成長。另一方面，對罕見疾病診斷的日益關注代表著該行業參與企業的高成長潛力。生物標記在罕見疾病藥物開發中發揮重要作用。生物標記的使用可以幫助識別適合臨床測試的患者並降低成本。基因組學和蛋白​​質組學等生物標記分析技術的日益普及將在不久的將來帶來豐厚的機會。

研究的主要特點

本報告對全球生物標記研究服務市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），以 2024 年為基準年。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球生物標誌研究服務市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。

研究涉及的主要企業包括 F. Hoffmann-La Roche Ltd.、雅培實驗室、賽默飛世爾科技公司、Bio-Rad Laboratories, Inc.、西門子醫療公司、強生服務公司、Qiagen、Epigenetics AG、通用電氣、默克集團、Illumina, Inc.、珀金埃爾默公司、安諾華、通用電氣公司和華倫科技公司。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球生物標記研究服務市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。

相關人員可以透過全球生物標記研究服務市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 影響分析
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購情景
• 產業趨勢

4. 2020 年至 2032 年全球生物標記研究服務市場（按服務類型分類）（十億美元）

• 介紹
• 生物標記研究服務
• 伴同性診斷 (CDx) 研究服務

5. 2020 年至 2032 年全球生物標記研究服務市場（按適應症分類）（十億美元）

• 介紹
• 癌症
• 心血管疾病
• 感染疾病
• 神經系統疾病
• 免疫系統疾病
• 其他

6. 2020-2032 年全球生物標記研究服務市場（按最終用戶分類）（十億美元）

• 簡介
• 醫院
• 診斷中心
• 專業中心
• 研究所

7. 2020 年至 2032 年全球生物標記研究服務市場（按地區分類）金額（十億美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭格局

• Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers AG
• Johnson & Johnson Services, Inc.
• Qiagen
• Epigenetics AG
• General Electric
• Merck KGaA
• Illumina, Inc.
• PerkinElmer, Inc.
• Agilent Technologies
• Becton, Dickinson and Company
• Novartis AG

第 9 章分析師建議

• 興衰
• 一致的機會地圖

第10章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Global Biomarker Research Services Market is estimated to be valued at USD 10.98 Bn in 2025 and is expected to reach USD 310.66 Bn by 2032, growing at a compound annual growth rate (CAGR) of 61.2% from 2025 to 2032.

Figure. Biomarker Research Services Market Share (%), By Region 2025

The global biomarker research services market has been gaining significant traction over the recent past, owing to rising penetration of precision medicine and personalized healthcare. Biomarkers play a crucial role in drug development by identifying the risk of diseases and patients' response to therapies. They help streamline clinical trials and reduce costs associated with drug development. With increasing focus on biomarkers for early diagnosis of diseases and the development of targeted therapies, there has been huge demand for outsourced biomarker research services. Various biopharmaceutical companies are collaborating with research organizations to tap into their expertise and maximize efficiency of clinical research. This has boosted the growth of the global biomarker research services market.

Market Dynamics:

Global biomarker research services market is driven by rising demand for personalized medicine, increasing influence of precision medicine, and growth of companion diagnostics market. However, high costs associated with biomarker discovery and validation, and technical challenges in biomarker discovery are likely to restrain the market growth. Meanwhile, increasing focus on rare disease diagnosis presents high growth potential for players in this industry. Biomarkers play a critical role in drug development for rare diseases. Their use helps identify patients suitable for clinical trials and reduces costs. Growing adoption of biomarker profiling technologies, such as genomics and proteomics, offer lucrative opportunities in the near future.

Key Features of the Study:

This report provides in-depth analysis of the global biomarker research services market, and provides market size (US$ Billion) and the compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global biomarker research services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Johnson & Johnson Services, Inc., Qiagen, Epigenetics AG, General Electric, Merck KGaA, Illumina, Inc., PerkinElmer, Inc., Agilent Technologies, Becton, Dickinson and Company, and Novartis AG

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global biomarker research services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biomarker research services market

Market Segmentation

• By Service Type Insights (Revenue, USD Bn, 2019 - 2032)
  • Biomarker Research Services
  • Companion Diagnostics (CDx) Research Services
• By Disease Indication Insights (Revenue, USD Bn, 2019 - 2032)
  • Cancer
  • Cardiovascular Disorders
  • Infectious Diseases
  • Neurological Disorders
  • Immunological Disorders
  • Others
• By End User Insights (Revenue, USD Bn, 2019 - 2032)
  • Hospitals
  • Diagnostic Centers
  • Specialty Centers
  • Research Institutions
• Regional Insights (Revenue, USD Bn, 2019 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers AG
  • Johnson & Johnson Services, Inc.
  • Qiagen
  • Epigenetics AG
  • General Electric
  • Merck KGaA
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Novartis AG

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Biomarker Research Services Market, By Service Type
  • Global Biomarker Research Services Market, By Disease Indication
  • Global Biomarker Research Services Market, By End User
  • Global Biomarker Research Services Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Biomarker Research Services Market, By Service Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biomarker Research Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Companion Diagnostics (CDx) Research Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Biomarker Research Services Market, By Disease Indication, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiovascular Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Biomarker Research Services Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Biomarker Research Services Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Indication , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson Services, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qiagen
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Epigenetics AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• General Electric
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
• Illumina, Inc.
• PerkinElmer, Inc.
• Agilent Technologies
• Becton, Dickinson and Company
• Novartis AG

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us